Pay in 4 interest-free payments of $5.68 Learn more
Ships within 48 hours · Estimated delivery Jul 31 - Aug 5
The companys 2025 guidance is for a decline of nearly $3bn on 2024s revenues
Maximum efficacy was observed at 12mg with 24.2% average weight loss
Global Glp 1 Receptor Agonists Obesity Drugs Market Market Size in USD Billion GLP-1 Receptor Agonists Obesity Drugs Market Size The global GLP-1 receptor agonists obesity drugs market size was valued at USD 9.96 billion in 2024 and is expected to reach USD 33.12 billion by 2032 , at a CAGR of 16.21% during the forecast period The market growth is primarily driven by the increasing need for secure, transparent, and tamper-proof systems to manage sensitive healthcare data, billing processes, and patient records across diverse stakeholders In addition, the rising adoption of blockchain technology by healthcare providers, insurers, and pharmaceutical companies to streamline operations, enhance data integrity, and mitigate fraud is propelling market expansion
L-Carnitine For Liver Health The Evidence The totality of human evidence looking at L-carnitine supplementation in people living with NAFLD is very limited
So the first medication to actually come out onto the market was exenatide, and that was back in 2005
US$ 25.20
US$ 25.07
US$ 23.72
